Charles River Laboratories stock holds near its yearly high

Published on 09/22/2026 at 12:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Charles River Laboratories stock closed at USD 278.06 on September 18, 2026, after a 1.28 percent decline. Fiscal 2026 EPS guidance is USD 11.15 to USD 11.45.

Moderner CRO-Forschungscampus mit Glasfassade in Wilmington Massachusetts — Charles River Laboratories Forschungscampus in Wilmington Massachusetts, modernes Glaslaborgebäude, ISIN US1591881009, Außenansicht, Illustration mit AI erstellt.

Charles River Laboratories stock (ISIN US1591881009) closed at USD 278.06 on the NYSE on September 18, 2026, down 1.28 percent, while the 52-week range stood at USD 144.26 to USD 303.31. The closing level was USD 25.25 below the yearly high, keeping the share close to its strongest level of the past year.

Guidance anchors valuation

Fiscal 2026 earnings per share guidance is USD 11.15 to USD 11.45, according to MarketBeat on September 21, 2026. The midpoint of USD 11.30 is below the analyst expectation of USD 11.33 by USD 0.03, leaving the guidance range as the key numerical reference for the valuation.

The latest reported second-quarter fiscal 2026 data cited by Yahoo Finance show revenue of USD 1 billion and earnings of negative USD 1.48 million. The same data set lists actual EPS of USD 3.02 against an estimate of USD 2.74, a positive difference of USD 0.28 for that quarter.

Analyst target moves higher

Evercore ISI maintained an Outperform rating and raised its price target from USD 300 to USD 320 on September 11, 2026, according to Yahoo Finance. The new target is USD 41.94 above the September 18 closing price, while the average one-year target shown in the same data set is USD 282.43.

The contrast is material: Evercore's USD 320 target is above the average target of USD 282.43 by USD 37.57, whereas the stock closed only USD 4.37 below that average. That spread indicates that the bullish case depends on earnings growth reaching the fiscal 2026 guidance range rather than on a broad analyst consensus alone.

Stock remains below the high

Market data for September 18, 2026 show a trading range of USD 276.01 to USD 282.99 and volume of 1,481,163 shares. Market capitalization was USD 13.394 billion on the same data snapshot, while the share remained USD 133.80 above its 52-week low.

Charles River Laboratories stock closed at USD 278.06 on the NYSE on September 18, 2026. The price is the reference level for the article and sits between the reported 52-week low of USD 144.26 and high of USD 303.31.